journal article·2024-02-28Open access

Organophosphate Detoxification and Acetylcholinesterase Reactivation Triggered by Zeolitic Imidazolate Framework Structural Degradation

Javier D. Martin-Romera, Emilio Borrego-Marin, Pedro J. Jabalera-Ortiz, Francesco Carraro, Paolo Falcaro, Elisa Barea, Francisco J. Carmona, Jorge A. R. Navarro

Abstract

High Resolution Image Download MS PowerPoint Slide Organophosphate (OP) toxicity is related to inhibition of acetylcholinesterase (AChE) activity, which plays a key role in the neurotransmission process. In this work, we report the ability of different zinc zeolitic imidazolate frameworks (ZIFs) to behave as potential antidotes against OP poisoning. The Zn–L coordination bond (L = purine, benzimidazole, imidazole, or 2-methylimidazole) is sensitive to the G-type nerve agent model compounds diisopropylfluorophosphate (DIFP) and diisopropylchlorophosphate, leading to P–X (X = F or Cl) bond breakdown into nontoxic diisopropylphosphate. P–X hydrolysis is accompanied by ZIF structural degradation (Zn–imidazolate bond hydrolysis), with the concomitant release of the imidazolate linkers and zinc ions representing up to 95% of ZIF particle dissolution. The delivered imidazolate nucleophilic attack on the OP@AChE adduct gives rise to the recovery of AChE enzymatic function. P–X bond breakdown, ZIF structural degradation, and AChE reactivation are dependent on imidazolate linker nucleophilicity, framework topology, and particle size. The best performance is obtained for 20 nm nanoparticles (NPs) of Zn(2-methylimidazolate) 2 (sod ZIF-8) exhibiting a DIFP degradation half-life of 2.6 min and full recovery of AChE activity within 1 h. 20 nm sod ZIF-8 NPs are not neurotoxic, as proven by in vitro neuroblastoma cell culture viability tests.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Chemical Synthesis and Characterization · Sulfur Compounds in Biology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Departamento de Química Inorgánica, Universidad de Granada, Av. Fuentenueva S/N, Granada 18071, Spain

Institute of Physical and Theoretical Chemistry, TU Graz, Stremayrgasse 9, Graz A-8010, Austria

Funding

North Atlantic Treaty Organization · Agencia Estatal de Investigaci?n · Vicerrectorado de Investigaci?n y Transferencia, Universidad de Granada

References (46)

Show source-provided references
1. 10.1038/3506758910.1038/35067589 ↗
2. 10.1016/j.bcp.2004.07.03810.1016/j.bcp.2004.07.038 ↗
3. 10.1021/acs.chemrev.9b0082810.1021/acs.chemrev.9b00828 ↗
4. Giannakoudakis D. A. · 201810.1007/978-3-319-70760-0 ↗
5. 10.1038/s41467-018-03878-610.1038/s41467-018-03878-6 ↗
6. 10.1039/D2TA02074B10.1039/D2TA02074B ↗
7. 10.1021/acscatal.0c0456510.1021/acscatal.0c04565 ↗
8. 10.1021/acsami.2c0602510.1021/acsami.2c06025 ↗
9. 10.1021/acs.inorgchem.3c0012110.1021/acs.inorgchem.3c00121 ↗
10. 10.1016/S0140-6736(06)69862-010.1016/S0140-6736(06)69862-0 ↗
11. 10.1007/s00204-020-02797-010.1007/s00204-020-02797-0 ↗
12. 10.1016/j.cbi.2017.09.01610.1016/j.cbi.2017.09.016 ↗
13. 10.1073/pnas.060243910310.1073/pnas.0602439103 ↗
14. 10.1126/science.115251610.1126/science.1152516 ↗
15. 10.1039/C4CS00230J10.1039/C4CS00230J ↗
16. 10.1039/C9SC05433B10.1039/C9SC05433B ↗
17. 10.1016/j.ccr.2015.08.00810.1016/j.ccr.2015.08.008 ↗
18. 10.1039/C9CS00472F10.1039/C9CS00472F ↗
19. 10.1039/D1TB01044A10.1039/D1TB01044A ↗
20. National Center for Biotechnology Information. Imidazole. https://pubchem.ncbi.nlm.nih.gov/compound/795#section=Acute-Effects (accessed June 12, 2023).
21. 10.1016/j.ccr.2020.21365110.1016/j.ccr.2020.213651 ↗
22. 10.1021/acsami.1c0565710.1021/acsami.1c05657 ↗
23. 10.1039/D3SC00500C10.1039/D3SC00500C ↗
24. 10.1021/jacs.1c0390110.1021/jacs.1c03901 ↗
25. 10.1021/acsami.0c1298510.1021/acsami.0c12985 ↗
26. 10.1021/acsanm.1c0054010.1021/acsanm.1c00540 ↗
27. 10.1016/j.mcat.2020.11096510.1016/j.mcat.2020.110965 ↗
28. 10.1039/c3dt52103f10.1039/c3dt52103f ↗
29. 10.1039/b302840b10.1039/b302840b ↗
30. 10.1021/cm103571y10.1021/cm103571y ↗
31. 10.1039/c3cc44342f10.1039/c3cc44342f ↗
32. 10.1002/anie.20201688210.1002/anie.202016882 ↗
33. 10.1002/1099-0682(200012)2000:12<2507::AID-EJIC2507>3.0.CO;2-X10.1002/1099-0682(200012)2000:12<2507::AID-EJIC2507>3.0.CO;2-X ↗
34. 10.3390/ijms1204263110.3390/ijms12042631 ↗
35. 10.1021/jp049076y10.1021/jp049076y ↗
36. 10.1016/j.ab.2007.07.02310.1016/j.ab.2007.07.023 ↗
37. 10.1038/nmat192710.1038/nmat1927 ↗
38. 10.1038/s42004-021-00613-z10.1038/s42004-021-00613-z ↗
39. 10.1021/acs.chemmater.7b0497710.1021/acs.chemmater.7b04977 ↗
40. Dym, O.; Aggarwal, N.; Albeck, S.; Unger, T.; Hamer Rogotner, S.; Silman, I.; Leader, H.; Ashani, Y.; Goldsmith, M.; Greisen, P.; Tawfik, D.; Sussman, L. J. Phosphotriesterase PTE_C23_5. 2018.10.2210/pdb6fw1/pdb ↗
41. 10.1002/aoc.438310.1002/aoc.4383 ↗
42. 10.1021/bi960325l10.1021/bi960325l ↗
43. 10.1021/acssensors.7b0081610.1021/acssensors.7b00816 ↗
44. 10.1039/C7NH00081B10.1039/C7NH00081B ↗
45. 10.1016/0025-5408(88)90019-010.1016/0025-5408(88)90019-0 ↗
46. 10.1093/jnci/71.4.74110.1093/jnci/71.4.741 ↗